Introduction: One in three US adults is living with obesity or hypertension, and more than 75% of hypertensive individuals are using antihypertensive medications. Therefore, it is important to examine blood pressure (BP) differences in populations that are using these medications with differing obesity status.

Aim: We examined whether BP attained when using various antihypertensive medications varies amongst different body mass index (BMI) categories and whether antihypertensive medication use is associated with differences in other metabolic risk factors, independent of BMI.

Methods: Adults with hypertension from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2014 were used (=15,285). Linear regression analyses were used to examine the main effects and interaction between antihypertensive use and BMI.

Results: In general, users of antihypertensive medications had lower BP than those not taking BP medications (NoBPMed) ( < 0.05), whereby in women, the differences in systolic BP between angiotensin-converting-enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) users and NoBPMed were greater in those with obesity (ACE inhibitors: -14 ± 1 mmHg; ARB: -16 ± 1 mmHg) compared to normal weight individuals (ACE inhibitors: -9 ± 1 mmHg; ARB: -11 ± 1 mmHg) ( < 0.05). Diastolic BP differences between women ARB users and NoBPMed were also greatest in obesity (-5 ± 1 mmHg) ( < 0.05) whilst there were no differences in normal weight individuals (-1 ± 1 mmHg) (>0.05). Furthermore, glucose levels and waist circumference in women were higher in those using ACE inhibitors compared to diuretics ( < 0.05).

Conclusion: ACE inhibitors and ARBs may be associated with more beneficial BP profiles in women with obesity, with no obesity-related BP differences for antihypertensive medication in men. However, there could be potential cardiometabolic effects for some antihypertensive medications that should be explored further.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188586PMC
http://dx.doi.org/10.1155/2018/4573258DOI Listing

Publication Analysis

Top Keywords

antihypertensive medications
16
ace inhibitors
16
antihypertensive medication
12
blood pressure
8
arb users
8
users nobpmed
8
normal weight
8
weight individuals
8
antihypertensive
7
obesity
6

Similar Publications

Sweet almond expeller is an abundant protein resource, but there are few studies on multifunctional peptides. The purpose of this study is to improve its application in food and medical industries. This study investigated the identification, screening, and action mechanisms of antihypertensive peptides with antioxidant and ferrous binding activities derived from sweet almond globulin hydrolysates using intergrade in vitro and in silico methods and an animal model.

View Article and Find Full Text PDF

Alzheimer's disease is a progressive neurodegenerative disorder with limited treatment options. Lingonberry ( L.) has demonstrated neuroprotective and anti-inflammatory properties, yet the underlying mechanisms remain unclear.

View Article and Find Full Text PDF

The misuse of opioids and opiates has remained a persistent issue since the 19th century. The recent resurgence of non-fentanyl synthetic opioids, such as U-type opioids and nitazenes, has further exacerbated the ongoing crisis. Identifying these synthetic opioids presents many challenges, including the emergence of new substances, the lack of standards, and the presence of structural isomers.

View Article and Find Full Text PDF

Arterial hypertension and diabetes mellitus are components of the cardiometabolic syndrome that arises from a sedentary lifestyle, excess calorie intake, and obesity. Swietenia humilis Zucc has been used in traditional Mexican medicine for the treatment of diabetes mellitus; this work investigated the antioxidant, antidiabetic, and vasorelaxant effects of ethanolic extract of S. humilis seeds.

View Article and Find Full Text PDF

The main objectives of this study were to develop an optimized green extraction process to obtain high contents of oleuropein and flavonoids from olive leaves. A deep eutectic solvent (DES) combined with wall-breaking extraction (WBE) was employed. A DES composed of choline chloride and ethylene glycol in a 1:2 molar ratio with 30% moisture content outperformed lactic acid and methanol as extraction solvents.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!